Prognostic Significance of Inflammatory, Cellular, and Tumor-Specific Biomarkers in Patients With Pleural and Peritoneal Mesothelioma
Clinical Lung Cancer · 2026-06 · 27 (5) · 77-86.e1
DOI: 10.1016/j.cllc.2026.04.005 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Lung Cancer, 2026-06. Verfasst von Keval Yerigeri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine-Pediatrics, Case Western Reserve University, The MetroHealth System, Cleveland, OH. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Inflammation, Mesothelioma, Peritoneal Neoplasms. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, Center for Cancer Research, U.S. Department of Health and Human Services.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine-Pediatrics, Case Western Reserve University, The MetroHealth System, Cleveland, OH.
- Thoracic and GI Malignancies Branch, National Cancer Institute, Bethesda, MD.
- Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD. Electronic address: Jeevan.Puthiamadathil@fda.hhs.gov.
- Thoracic and GI Malignancies Branch, National Cancer Institute, Bethesda, MD. Electronic address: hassanr@mail.nih.gov.
Förderung
- Intramural NIH HHS
- Center for Cancer Research
- U.S. Department of Health and Human Services
- Colgate-Palmolive
- National Institutes of Health
- National Institutes of Health National Cancer Institute
- Doris Duke Charitable Foundation
- American Association for Dental, Oral, and Craniofacial Research
Zitieren
APA
Yerigeri, K., Sengupta, M., Zhang, J., Puthiamadathil, J., & Hassan, R. (2026). Prognostic Significance of Inflammatory, Cellular, and Tumor-Specific Biomarkers in Patients With Pleural and Peritoneal Mesothelioma. Clinical Lung Cancer, 27(5), 77-86.e1. https://doi.org/10.1016/j.cllc.2026.04.005
Vancouver
Yerigeri K, Sengupta M, Zhang J, Puthiamadathil J, Hassan R. Prognostic Significance of Inflammatory, Cellular, and Tumor-Specific Biomarkers in Patients With Pleural and Peritoneal Mesothelioma. Clinical Lung Cancer. 2026;27(5):77-86.e1. doi:10.1016/j.cllc.2026.04.005
BibTeX
@article{Yerigeri2026,
author = {Yerigeri, Keval and Sengupta, Manjistha and Zhang, Jingli and Puthiamadathil, Jeevan and Hassan, Raffit},
title = {Prognostic Significance of Inflammatory, Cellular, and Tumor-Specific Biomarkers in Patients With Pleural and Peritoneal Mesothelioma},
journal = {Clinical Lung Cancer},
year = {2026},
volume = {27},
number = {5},
pages = {77--86.e1},
doi = {10.1016/j.cllc.2026.04.005}
}
EUVIMED